News Archive 2007
9 November 2007 Hanseatic India Colloquium
Pharmaceutical, Biotechnology and Healthcare
Guest House of the University of Hamburg

The second Hanseatic India Colloquium was held in Hamburg to show-case the progress that India has made in the field of life sciences and to provide a platform for an effective networking between India and German/European companies with a focus on co-operation in the field of pharmaceuticals, biotechnology and healthcare. The response was excellent and the presentations by reputed speakers at the Colloquium were highly appreciated by the audience. Photographs taken at the colloquium and PowerPoint presentations by the speakers who consented can be viewed as indicated below.

Pictures of the Colloquium
Investment in India: Risks and Opportunities
Mr. Olaf Meuser, Managing Director, Head of Region Hamburg and Schleswig-Holstein, Corporate Banking, Deutsche Bank AG, Hamburg, Germany
Opportunities in Healthcare: Indo-German Cooperation
Dr. Amal K. Mukhopadhyay, Founder and Director, ELGA Biotech, Hamburg, Germany
Vaccines and Microreactors: From Basic Science to Business Opportunities
Prof. Dr. Peter Seeberger, Professor for Organic Chemistry, Recipient of Koerber Prize 2007, Laboratory for Organic Chemistry, ETH Zürich, Switzerland
Market Opportunities and Market Entry Strategies for Small to Mid-size Companies
Reinhard Vogt, Vice Chief Executive Officer, Sartorius Stedim Biotech, Göttingen, Germany
Venus Pharma GmbH - The Case Study of an Indian-German company's effort to build a Global Pharma Company
Mr. Sisir Gupta, COO, Venus Pharma GmbH, Werne, Germany and Chandigarh, India
Development of Generic Medicine in India - Creation of an Indo-German Win-Win Situation
Dr. Georg Stark, Managing Director of Alfred E. Tiefenbacher GmbH & Co. KG, Hamburg, Germany
The Centre for Bioinformatics - Drug Design, Genomes and Protein Structure
Prof. Dr. Andrew Torda, Centre for Bioinformatics, University of Hamburg, Germany
Insilico Target Discovery – A Road to IP Development
Mr. Naveen Kulkarni, Polyclone Bioservices, Bangalore, India
Global market – global healthcare? Handling sensitive medical data in an unsecure world
Dr. Uwe Eissing, Managing Director, Mednet Service für Ärzte AG, Cologne, Germany
Opportunities in E-Health – A Perspective from India
Mr. Kurian Babykutty, Business Development Executive, Katrasoft GmbH, Hamburg and Bangalore
The Electronic Public Record (EPR): Implementations and Availability in the Healthcare Systems of Italy, France and Germany
PD Dr. Peter Stritzke, Managing Director, Econmed GmbH, Hüllhorst, Germany
November 2007 Dr. Mukhopadhyay joined Gateway Knowledge Partners ( as their Director of India Operations. In this position he will be responsible for India desk of the organisation.
July 2007 Representative of Hamburg for India: Dr. Mukhopadhyay is appointed as the Representative for Hamburg in Life Sciences for India by the Hamburg Business Development Corporation (HWF, In this capacity he will be responsible for representing Hamburg in India and will look after Indo-German business relationships specifically in Life Sciences that will include biotechnology, bioinformatics, clinical research, healthcare, pharmaceuticals and related areas.
March 2007 A successful business visit to India organised in co-operation with German India Round Table ( Dr. Mukhopadhyay visited India as a leader of the Group, “Healthcare, Pharmaceutical, Biotechnology and Chemical Sciences” under the German delegation “Mittelstand Goes to India/NRW Goes to India”.
January 2007 KatraSoft Europe GmbH: Dr. Mukhopadhyay has been instrumental in setting up KatraSoft Europe GmbH ( in Hamburg. This is a specialist company for software development and services for healthcare, hospital management, agriculture and contract farming. He is appointed as their Director, European operation.
© 2007-2020 ELGA BIOTECH